Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire De Canecaude

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 4, 2022
Increased reporting of venous and arterial thromboembolic events reported with tixagevimab-cilgavimab for coronavirus disease 2019François Montastruc, Margaux Lafaurie, Clara Flumian, et al.
Fundamental & Clinical Pharmacology|January 29, 2021
Tramadol-induced hypoglycemia: A pharmacovigilance studyClaire De Canecaude, Vanessa Rousseau, Agnès Sommet, et al.
European Journal of Clinical Pharmacology|June 3, 2020
Role of serotonin and norepinephrine transporters in antidepressant-induced arterial hypertension: a pharmacoepidemiological-pharmacodynamic studyJean-Louis Montastruc, Vanessa Rousseau, Claire de Canecaude, et al.
Expert Opinion on Drug Safety|August 16, 2023
Sublingual/Buccal buprenorphine and dental problems: a pharmacovigilance studyRomain Barus, François Montastruc, Claire de Canecaude, et al.
Therapie|May 2, 2020
Interest of a general practitioner pharmacovigilance network to provide drug information: A comparative study in FranceJulien Jacquot, Vanessa Rousseau, Claire de Canecaude, et al.
Therapie|March 14, 2023
French pharmacovigilance survey of casirivimab - imdevimab monoclonal antibodies in coronavirus disease (COVID-19)Claire de Canecaude, François Montastruc, Sandrine Bergeron, et al.
British Journal of Clinical Pharmacology|May 30, 2020
Can tramadol really induce hyponatraemia? A pharmacovigilance studyClaire de Canecaude, Vanessa Rousseau, Leila Chebane, et al.
British Journal of Clinical Pharmacology|April 10, 2021
Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance databaseJean-Louis Montastruc, Margaux Lafaurie, Claire de Canecaude, et al.
Therapie|June 13, 2021
COVID-19 vaccines: A perspective from social pharmacologyJean-Louis Montastruc, Margaux Lafaurie, Claire de Canecaude, et al.
British Journal of Clinical Pharmacology|June 18, 2026
Applying machine learning to pharmacovigilance data: A proof-of-concept studyRomain Barus, Pauline Schiro, Jean-Luc Faillie, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 4, 2022
Increased reporting of venous and arterial thromboembolic events reported with tixagevimab-cilgavimab for coronavirus disease 2019François Montastruc, Margaux Lafaurie, Clara Flumian, et al.
Fundamental & Clinical Pharmacology|January 29, 2021
Tramadol-induced hypoglycemia: A pharmacovigilance studyClaire De Canecaude, Vanessa Rousseau, Agnès Sommet, et al.
European Journal of Clinical Pharmacology|June 3, 2020
Role of serotonin and norepinephrine transporters in antidepressant-induced arterial hypertension: a pharmacoepidemiological-pharmacodynamic studyJean-Louis Montastruc, Vanessa Rousseau, Claire de Canecaude, et al.
Expert Opinion on Drug Safety|August 16, 2023
Sublingual/Buccal buprenorphine and dental problems: a pharmacovigilance studyRomain Barus, François Montastruc, Claire de Canecaude, et al.
Therapie|May 2, 2020
Interest of a general practitioner pharmacovigilance network to provide drug information: A comparative study in FranceJulien Jacquot, Vanessa Rousseau, Claire de Canecaude, et al.
Therapie|March 14, 2023
French pharmacovigilance survey of casirivimab - imdevimab monoclonal antibodies in coronavirus disease (COVID-19)Claire de Canecaude, François Montastruc, Sandrine Bergeron, et al.
British Journal of Clinical Pharmacology|May 30, 2020
Can tramadol really induce hyponatraemia? A pharmacovigilance studyClaire de Canecaude, Vanessa Rousseau, Leila Chebane, et al.
British Journal of Clinical Pharmacology|April 10, 2021
Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance databaseJean-Louis Montastruc, Margaux Lafaurie, Claire de Canecaude, et al.
Therapie|June 13, 2021
COVID-19 vaccines: A perspective from social pharmacologyJean-Louis Montastruc, Margaux Lafaurie, Claire de Canecaude, et al.
British Journal of Clinical Pharmacology|June 18, 2026
Applying machine learning to pharmacovigilance data: A proof-of-concept studyRomain Barus, Pauline Schiro, Jean-Luc Faillie, et al.
Pageof 2